These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27759479)

  • 1. MDMB-CHMICA: Availability, Patterns of Use, and Toxicity Associated With This Novel Psychoactive Substance.
    Haden M; Archer JR; Dargan PI; Wood DM
    Subst Use Misuse; 2017 Jan; 52(2):223-232. PubMed ID: 27759479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytically Confirmed Intoxications Involving MDMB-CHMICA from the STRIDA Project.
    Bäckberg M; Tworek L; Beck O; Helander A
    J Med Toxicol; 2017 Mar; 13(1):52-60. PubMed ID: 27638057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study.
    Hill SL; Najafi J; Dunn M; Acheampong P; Kamour A; Grundlingh J; Blain PG; Thomas SH
    Clin Toxicol (Phila); 2016 Sep; 54(8):638-43. PubMed ID: 27251903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the Psychoactive Substances Act 2016 on the online availability of MDMB-CHMICA.
    Haden M; Wood DM; Dargan PI
    QJM; 2017 Oct; 110(10):619-622. PubMed ID: 28339898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis and clinical findings of cases positive for the novel synthetic cannabinoid receptor agonist MDMB-CHMICA.
    Seywright A; Torrance HJ; Wylie FM; McKeown DA; Lowe DJ; Stevenson R
    Clin Toxicol (Phila); 2016 Sep; 54(8):632-7. PubMed ID: 27213960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.
    Franz F; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2017 May; 9(5):744-753. PubMed ID: 27504870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical profiling of the synthetic cannabinoid MDMB-CHMICA: Identification, assessment, and stability study of synthesis-related impurities in seized and synthesized samples.
    Münster-Müller S; Hansen S; Opatz T; Zimmermann R; Pütz M
    Drug Test Anal; 2019 Aug; 11(8):1192-1206. PubMed ID: 31124282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.
    Hermanns-Clausen M; Müller D; Kithinji J; Angerer V; Franz F; Eyer F; Neurath H; Liebetrau G; Auwärter V
    Clin Toxicol (Phila); 2018 Jun; 56(6):404-411. PubMed ID: 29072524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal intoxication with synthetic cannabinoid MDMB-CHMICA.
    Adamowicz P
    Forensic Sci Int; 2016 Apr; 261():e5-10. PubMed ID: 26934903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxication.
    Gaunitz F; Lehmann S; Thomas A; Thevis M; Rothschild MA; Mercer-Chalmers-Bender K
    Int J Legal Med; 2018 Nov; 132(6):1645-1657. PubMed ID: 30219927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Impurity-Profiling Workflow with the Combination of Flash-Chromatography, UHPLC-MS, and Multivariate Data Analysis for Highly Pure Drugs: A Study on the Synthetic Cannabinoid MDMB-CHMICA.
    Münster-Müller S; Zimmermann R; Pütz M
    Anal Chem; 2018 Sep; 90(17):10559-10567. PubMed ID: 30079731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) into Schedule I. Temporary Scheduling Order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2017 Apr; 82(67):17119-24. PubMed ID: 28425681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues.
    Banister SD; Longworth M; Kevin R; Sachdev S; Santiago M; Stuart J; Mack JB; Glass M; McGregor IS; Connor M; Kassiou M
    ACS Chem Neurosci; 2016 Sep; 7(9):1241-54. PubMed ID: 27421060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethylphenidate: availability, patterns of use, and acute effects of this novel psychoactive substance.
    Ho JH; Bailey GP; Archer JR; Dargan PI; Wood DM
    Eur J Clin Pharmacol; 2015 Oct; 71(10):1185-96. PubMed ID: 26195274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB- CHMICA and MDMB-FUBINACA) Into Schedule I. Notice of Intent.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 Dec; 81(245):93595-9. PubMed ID: 28068047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and analytical experience of the National Poison Control Centre with synthetic cannabinoids.
    Vučinić S; Kilibarda V; Đorđević S; Đorđević D; Perković-Vukčević N; Vuković-Ercegović G; Antonijević B; Ćurčić M; Antonijević E; Brajković G
    Arh Hig Rada Toksikol; 2018 Jun; 69(2):178-185. PubMed ID: 29990297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4'-DMAR, 4,4'-dimethylaminorex): availability, prevalence of use, desired effects and acute toxicity.
    Glanville J; Dargan PI; Wood DM
    Hum Psychopharmacol; 2015 May; 30(3):193-8. PubMed ID: 25784180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of third generation synthetic cannabinoids using zebrafish larvae.
    Morales-Noé A; Esteve-Turrillas FA; Armenta S
    Drug Test Anal; 2022 Apr; 14(4):594-603. PubMed ID: 34750997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first half of 2015.
    Abouchedid R; Hudson S; Thurtle N; Yamamoto T; Ho JH; Bailey G; Wood M; Sadones N; Stove CP; Dines A; Archer JRH; Wood DM; Dargan PI
    Clin Toxicol (Phila); 2017 Jun; 55(5):338-345. PubMed ID: 28421836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poisoning due to MDMB-CHMICA, a synthetic cannabinoid receptor agonist.
    Meyyappan C; Ford L; Vale A
    Clin Toxicol (Phila); 2017 Feb; 55(2):151-152. PubMed ID: 27635694
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.